# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-23-241475
Filing Date
2023-09-26
Accepted
2023-09-25 17:46:36
Documents
38
Period of Report
2023-09-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d539630d8k.htm iXBRL | 8-K | 26188
2 | EX-99.1 | d539630dex991.htm | EX-99.1 | 26243
6 | GRAPHIC | g539630ex99_1s10g1.jpg | GRAPHIC | 64135
7 | GRAPHIC | g539630ex99_1s11g1.jpg | GRAPHIC | 65038
8 | GRAPHIC | g539630ex99_1s12g1.jpg | GRAPHIC | 70970
9 | GRAPHIC | g539630ex99_1s13g1.jpg | GRAPHIC | 80958
10 | GRAPHIC | g539630ex99_1s14g1.jpg | GRAPHIC | 54024
11 | GRAPHIC | g539630ex99_1s15g1.jpg | GRAPHIC | 80322
12 | GRAPHIC | g539630ex99_1s16g1.jpg | GRAPHIC | 77682
13 | GRAPHIC | g539630ex99_1s17g1.jpg | GRAPHIC | 64785
14 | GRAPHIC | g539630ex99_1s18g1.jpg | GRAPHIC | 69804
15 | GRAPHIC | g539630ex99_1s19g1.jpg | GRAPHIC | 49180
16 | GRAPHIC | g539630ex99_1s1g1.jpg | GRAPHIC | 43060
17 | GRAPHIC | g539630ex99_1s20g1.jpg | GRAPHIC | 63654
18 | GRAPHIC | g539630ex99_1s21g1.jpg | GRAPHIC | 73516
19 | GRAPHIC | g539630ex99_1s22g1.jpg | GRAPHIC | 61971
20 | GRAPHIC | g539630ex99_1s23g1.jpg | GRAPHIC | 65967
21 | GRAPHIC | g539630ex99_1s24g1.jpg | GRAPHIC | 34994
22 | GRAPHIC | g539630ex99_1s25g1.jpg | GRAPHIC | 23133
23 | GRAPHIC | g539630ex99_1s2g1.jpg | GRAPHIC | 105507
24 | GRAPHIC | g539630ex99_1s3g1.jpg | GRAPHIC | 55490
25 | GRAPHIC | g539630ex99_1s4g1.jpg | GRAPHIC | 61850
26 | GRAPHIC | g539630ex99_1s5g1.jpg | GRAPHIC | 60705
27 | GRAPHIC | g539630ex99_1s6g1.jpg | GRAPHIC | 64256
28 | GRAPHIC | g539630ex99_1s7g1.jpg | GRAPHIC | 72428
29 | GRAPHIC | g539630ex99_1s8g1.jpg | GRAPHIC | 67967
30 | GRAPHIC | g539630ex99_1s9g1.jpg | GRAPHIC | 57839
| Complete submission text file | 0001193125-23-241475.txt |  | 2381153

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | cprx-20230926.xsd | EX-101.SCH | 2871
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cprx-20230926_lab.xml | EX-101.LAB | 18757
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cprx-20230926_pre.xml | EX-101.PRE | 11724
32 | EXTRACTED XBRL INSTANCE DOCUMENT | d539630d8k_htm.xml | XML | 3526

Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 231276729
SIC: 2834 Pharmaceutical Preparations